Ecat, Julieta .

HRN: 05-20-50  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/04/2023
05/10/2023
IV
1.5 G
Q24hours
Cervical Mass Prob Sec Fo Metastatic Colon Cancers/P Explore Lap, Diverting Colostomy
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Dose  Wrong Dose

Overall appropriateness: No  Wrong Dose

Intervention



Type of Intervention done:

                    

           


Acceptance: